Evidence map›Paper›PMID 26522270›Full record

ArticleScientific reports2015

NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.

Jillian P Casey, Svein I Støve, Catherine McGorrian, Joseph Galvin, Marina Blenski, Aimee Dunne, Sean Ennis, Francesca Brett, Mary D King, Thomas Arnesen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Neuroanatomical features of NAA10 and NAA15-related neurodevelopmental syndromes.Journal of neuroradiology = Journal de neuroradiologie · 2025
    Article
  4. Article
  5. Conformational plasticity links structural instability of NAA10Computational and structural biotechnology journal · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. A Case ofCJC pediatric and congenital heart disease · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. eLife · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jillian P CaseyClinical Genetics, Temple Street Children's University Hospital, Temple Street, Dublin 1, Ireland.
Svein I StøveDepartment of Molecular Biology, University of Bergen, Norway.
Catherine McGorrianDepartment of Cardiology, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland.
Joseph GalvinDepartment of Cardiology, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland.
Marina BlenskiDepartment of Molecular Biology, University of Bergen, Norway.
Aimee DunneUCD Academic Centre on Rare Diseases, School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland.
Sean EnnisUCD Academic Centre on Rare Diseases, School of Medicine and Medical Sciences, University College Dublin, Dublin 4, Ireland.
Francesca BrettDepartment of Neuropathology, Beaumont Hospital, Dublin 9, Ireland.
Mary D KingDepartment of Paediatric Neurology &Clinical Neurophysiology, Temple Street Children's University Hospital, Dublin 1, Ireland.
Thomas ArnesenDepartment of Molecular Biology, University of Bergen, Norway.
Sally Ann LynchClinical Genetics, Temple Street Children's University Hospital, Temple Street, Dublin 1, Ireland.
University College Dublin · IEUniversity of Bergen · NOMater Misericordiae University Hospital · IEBeaumont Hospital · IEChildren's Health Ireland at Crumlin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report two brothers from a non-consanguineous Irish family presenting with a novel syndrome characterised by intellectual disability, facial dysmorphism, scoliosis and long QT. Their mother has a milder phenotype including long QT. X-linked inheritance was suspected. Whole exome sequencing identified a novel missense variant (c.128 A > C; p.Tyr43Ser) in NAA10 (X chromosome) as the cause of the family's disorder. Sanger sequencing confirmed that the mutation arose de novo in the carrier mother. NAA10 encodes the catalytic subunit of the major human N-terminal acetylation complex NatA. In vitro assays for the p.Tyr43Ser mutant enzyme showed a significant decrease in catalytic activity and reduced stability compared to wild-type Naa10 protein. NAA10 has previously been associated with Ogden syndrome, Lenz microphthalmia syndrome and non-syndromic developmental delay. Our findings expand the clinical spectrum of NAA10 and suggest that the proposed correlation between mutant Naa10 enzyme activity and phenotype severity is more complex than anticipated; the p.Tyr43Ser mutant enzyme has less catalytic activity than the p.Ser37Pro mutant associated with lethal Ogden syndrome but results in a milder phenotype. Importantly, we highlight the need for cardiac assessment in males and females with NAA10 variants as both patients and carriers can have long QT.

Indexed as

AdultCell Line, TumorExomeFemaleHeLa CellsHumansIntellectual DisabilityLong QT SyndromeMaleN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EN-Terminal AcetyltransferasesPhenotypePolymorphism, Single NucleotideNAA10 protein, humanN-Terminal Acetyltransferase AN-Terminal Acetyltransferase EN-Terminal Acetyltransferases

Identifiers

PMID26522270
PMCPMC4629191
OpenAlexW2259202917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.